Attached files
| file | filename |
|---|---|
| EX-4.7 - EX-4.7 - International Stem Cell CORP | isco-ex47_187.htm |
| EX-31.1 - EX-31.1 - International Stem Cell CORP | isco-ex311_6.htm |
| EX-31.2 - EX-31.2 - International Stem Cell CORP | isco-ex312_9.htm |
| EX-32.2 - EX-32.2 - International Stem Cell CORP | isco-ex322_7.htm |
| EX-10.17 - EX-10.17 - International Stem Cell CORP | isco-ex1017_294.htm |
| 10-K - 10-K - International Stem Cell CORP | isco-10k_20201231.htm |
| EX-32.1 - EX-32.1 - International Stem Cell CORP | isco-ex321_11.htm |
Exhibit 23.1
Consent of Independent Registered Public Accounting Firm
International Stem Cell Corporation
San Diego, California
We hereby consent to the incorporation by reference in the Registration Statements on Form S-1 (Nos. 333-210840, 333-201589, and 333-199799) and Form S-8 (Nos. 333-226844, 333-211411, 333-206930, 333-169549, 333-166883, 333-166421, 333-166420, 333-164539, 333-159424, 333-159421, and 333-150920) of International Stem Cell Corporation (the “Company”) of our report dated March 30, 2021, relating to the consolidated financial statements, which appears in this Form 10-K. Our report contains an explanatory paragraph regarding the Company’s ability to continue as a going concern.
/s/ BDO USA, LLP
San Diego, California
March 30, 2021